🇺🇸 FDA
Patent

US 6706732

Nasal preparation of guanidinoimino quinoline derivatives

expired A61KA61K31/47A61K9/0043

Quick answer

US patent 6706732 (Nasal preparation of guanidinoimino quinoline derivatives) held by Takeda Chemical Industries Ltd. expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/47, A61K9/0043, A61P, A61P9/04